N@N

THRX, SHLD, FAST, RDY, MKTX, ESRX Are Seasonally Ripe To Go Up In the Next Five Weeks

March 5, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of THERAVANCE, INC. (NASDAQ:THRX), SEARS HOLDINGS CORP (NASDAQ:SHLD), FASTENAL COMPANY (NASDAQ:FAST), DOCTOR REDDY'S LAB-ADR (NYSE:RDY), MARKETAXESS HOLDINGS INC. (NASDAQ:MKTX), EXPRESS SCRIPTS INC (NASDAQ:ESRX) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Up:

     Symbol     Company                             Expected Return     Odds                    By The Following Date
     THRX       THERAVANCE, INC.                    11.82%              100.00% (7 of 7)        Thursday, April 12th 2012
     SHLD       SEARS HOLDINGS CORP                 16.78%              87.50% (7 of 8)         Wednesday, March 28th 2012
     FAST       FASTENAL COMPANY                    17.27%              91.67% (11 of 12)       Tuesday, April 17th 2012
     RDY        DOCTOR REDDY'S LAB-ADR              10.55%              90.00% (9 of 10)        Wednesday, April 4th 2012
     MKTX       MARKETAXESS HOLDINGS INC.           11.74%              85.71% (6 of 7)         Tuesday, April 3rd 2012
     ESRX       EXPRESS SCRIPTS INC                 5.73%               91.67% (11 of 12)       Thursday, April 5th 2012

THERAVANCE, INC. (NASDAQ:THRX) - Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines across various therapeutic areas, including respiratory disease, bacterial infections, and gastrointestinal motility dysfunction. Its key programs include VIBATIV with Astellas Pharma, Inc. approved in the United States and Canada for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant and methicillin-susceptible strains; RELOVAIR with GlaxoSmithKline (GSK), a Phase 3 clinical trial program for the treatment of patients with chronic obstructive pulmonary disease and/or asthma; and the Bifunctional Muscarinic Antagonist-beta2 Agonist program with GSK, which completed Phase 2a. The companys other pipeline programs under various clinical-stages comprise TD-1211, an oral peripheral Mu-opioid antagonist for the treatment of opioid-induced constipation; TD-5108 and TD-8954, 5HT-4 agonists for the treatment of gastrointestinal motility dysfunction and/or Alzheimers disease; TD-1792, an antibiotic for the treatment of serious infections caused by Gram-positive bacteria; and MARIN program (TD-9855) for the treatment of chronic pain. The company was formerly known as Advanced Medicine, Inc. and changed its name to Theravance, Inc. in April 2002. Theravance was founded in 1996 and is headquartered in South San Francisco, California.

SEARS HOLDINGS CORP (NASDAQ:SHLD) - Sears Holdings Corporation operates as a broadline retailer in the United States and Canada. Its Kmart segment operates stores that sell general merchandise under Jaclyn Smith and Joe Boxer labels, as well as Sears brand products, such as Kenmore, Craftsman, and DieHard. Its stores offer home appliances; footwear; groceries; and automotive accessories, repair, and maintenance services, as well as operate in-store pharmacies. The Kmart also sells its products through its kmart.com Web site. The companys Sears Domestic segment operates stores that offer merchandise categories, including home appliances, consumer electronics, tools, and fitness, lawn, and garden equipment; automotive services and products; home fashion products; and apparel, and footwear and accessories. Its stores also sell health and beauty products, pantry goods, household products, and toys. This segments direct to customer business offers clothing, accessories, footwear, and soft luggage; commercial business provides appliances and services to construction/remodel, property management, multi family new construction, and government/military sectors; appliances business provides appliance and plumbing fixtures to architects, designers, and new construction or remodeling customers; and home services business offers parts and repair services for home appliances, lawn and garden equipment, consumer electronics, floor care products, and heating and cooling systems, as well as provides home improvement services. The Sears Canada segment conducts retail operations in Canada, and offers apparel and other softlines. As of January 30, 2010, the company operated approximately 1,327 Kmart stores, 848 full-line stores, 60 Sears Essentials/Grand stores, and 1,284 specialty stores in the U.S.; and 122 full-line stores, 280 specialty stores, 22 floor covering stores, 1,853 catalog pick-up locations, and 108 travel offices in Canada. Sears Holdings was founded in 1899 and is based in Hoffman Estates, Illinois.

FASTENAL COMPANY (NASDAQ:FAST) - The Company Is Engaged As A Wholesaler And Retailer Of Industrial And Construction Supplies. The Industrial And Construction Supplies Were Grouped Into Ten Product Lines: Fasteners, Tools And EquipmeNt, Cutting Tools And Abrasives, Hydraulics, Pneumatics, Plumbing And Hvac, Material Handling, Storage And Packaging, Janitorial Supplies, Chemicals And Paints, Electrical Supplies, Welding Supplies, Safety Supplies And Metals, Alloys And Materials.

DOCTOR REDDY'S LAB-ADR (NYSE:RDY) - Dr. Reddys Laboratories Limited, together with its subsidiaries, operates as a pharmaceutical company. It produces finished dosage forms, active pharmaceutical ingredients and intermediates, and biotechnology products. The company also conducts research in the areas of cancer, diabetes, cardiovascular, inflammation, and bacterial infection. In addition, it involves in the contract manufacture generic prescription and over-the-counter products for branded and generic companies in the United States. The company primarily focuses on therapeutic categories of cardiovascular, diabetes management, gastro-intestinal, and pain management. It markets its products in India, the United States, Europe, and the Russian Federation. The company has a co-development and commercialization agreement with Rheoscience A/S for the development and commercialization of Balaglitazone/DRF 2593, a partial PPAR-gamma agonist for the treatment of type 2 diabetes; an agreement with ClinTec International for the development of an anti-cancer compound, DRF 1042; collaboration with the National Cancer Institute in Maryland; and an agreement with Argenta Discovery Limited for the joint development and commercialization of a novel approach to the treatment of chronic obstructive pulmonary disease. It also has an agreement with 7TM Pharma for drug discovery collaboration on selected drug targets; and an agreement with GlaxoSmithKline plc to develop and market pharmaceuticals for the treatment of cardiovascular disease, diabetes, oncology, gastroenterology, and pain management. Dr. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.

MARKETAXESS HOLDINGS INC. (NASDAQ:MKTX) - MarketAxess Holdings Inc. operates an electronic trading platform that enables investment industry professionals to trade corporate bonds and other types of fixed-income instruments. Its patented trading technology allows institutional investor clients to request competitive, executable bids, or offers from multiple broker-dealers simultaneously, and to execute trades with the broker-dealer of their choice. Approximately 800 institutional investors are users of the MarketAxess trading platform, accessing the global liquidity provided by MarketAxess' 78 broker-dealer clients in U.S. high-grade corporate bonds, European bonds, high yield and emerging markets bonds, agency bonds, asset-backed and preferred securities, and credit default swaps. The company also offers various trading-related products and services, including market data to assist clients with trading decisions; connectivity solutions that facilitate straight-through processing; technology services to optimize trading environments; and execution services for exchange-traded fund managers and other clients. MarketAxess was founded in 2000 and is headquartered in New York, New York.

EXPRESS SCRIPTS INC (NASDAQ:ESRX) - Express Scripts, Inc. provides a range of pharmacy benefit management (PBM) services in North America. The companys PBM services include retail network pharmacy management and retail drug card programs; home delivery pharmacy services; specialty pharmacy services; patient care contact centers; benefit plan design and consultation; drug formulary management; compliance and therapy management programs; information reporting and analysis programs; rebate programs, electronic claims processing, and drug utilization review; consumer health and drug information; bio-pharma services, including reimbursement and customized logistics solutions; medication therapy and safety through pharmacogenomics; and assistance programs for low-income patients. It also engages in the distribution of pharmaceuticals and medical supplies to providers and clinics; fertility pharmaceuticals requiring special handling or packaging; and sample units to physicians, as well as the verification of practitioner licensure, healthcare account administration, and implementation of consumer-directed healthcare solutions. It serves HMOs, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers compensation plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, and retina specialists. Express Scripts was founded in 1986 and is headquartered in St. Louis, Missouri.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641